1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes
    Journal Article

    Momtaz, P.; O'Connor, C. A.; Chou, J. F.; Capanu, M.; Park, W.; Bandlamudi, C.; Berger, M. F.; Kelsen, D. P.; Suehnholz, S. P.; Chakravarty, D.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+ selected allogeneic stem cell transplant
    Journal Article

    Alarcon Tomas, A.; Whiting, K.; Maloy, M.; Ruiz, J. D.; Devlin, S.; Sanchez-Escamilla, M.; YanĖƒez, L.; Castillo, N.; Pennisi, M.; Cho, C.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Oligometastases after curative esophagectomy are not one size fits all
    Journal Article

    Nobel, T. B.; Sihag, S.; Xing, X.; Eljalby, M.; Hsu, M.; Tan, K. S.; Sewell, D. B.; Bains, M. S.; Janjigian, Y.; Wu, A.; more...
    Annals of Thoracic Surgery (2021)

    Fulltext@MSK | Save
  • Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial
    Journal Article

    Luger, S. M.; Wang, V. X.; Rowe, J. M.; Litzow, M. R.; Paietta, E.; Ketterling, R. P.; Lazarus, H.; Rybka, W. B.; Craig, M. D.; Karp, J.; more...
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation
    Journal Article

    Mou, E.; Falchi, L.; Sundaram, V.; Abramson, J. S.; Balassanian, R.; Beygi, S.; Fitzpatrick, M. J.; Frank, A. K.; Gupta, S.; Lin, O.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Harnessing the benefits of available targeted therapies in acute myeloid leukaemia
    Review

    Kantarjian, H.; Short, N. J.; DiNardo, C.; Stein, E. M.; Daver, N.; Perl, A. E.; Wang, E. S.; Wei, A.; Tallman, M.
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): A single-arm, phase 1b and randomised, phase 2 trial
    Journal Article

    DiNardo, C. D.; Schuh, A. C.; Stein, E. M.; Montesinos, P.; Wei, A. H.; de Botton, S.; Zeidan, A. M.; Fathi, A. T.; Kantarjian, H. M.; Bennett, J. M.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Open-label phase II prospective, randomized, controlled study of romyelocel-L myeloid progenitor cells to reduce infection during induction chemotherapy for acute myeloid leukemia
    Journal Article

    Desai, P. M.; Brown, J.; Gill, S.; Solh, M. M.; Akard, L. P.; Hsu, J. W.; Ustun, C.; Andreadis, C.; Frankfurt, O.; Foran, J. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save